Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

Similar articles for PubMed (Select 20145170)

1.

Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center.

Pande M, Lynch PM, Hopper JL, Jenkins MA, Gallinger S, Haile RW, LeMarchand L, Lindor NM, Campbell PT, Newcomb PA, Potter JD, Baron JA, Frazier ML, Amos CI.

Clin Cancer Res. 2010 Feb 15;16(4):1331-9. doi: 10.1158/1078-0432.CCR-09-1877. Epub 2010 Feb 9.

2.

The effect of genotypes and parent of origin on cancer risk and age of cancer development in PMS2 mutation carriers.

Suerink M, van der Klift HM, Ten Broeke SW, Dekkers OM, Bernstein I, Capell√° Munar G, Gomez Garcia E, Hoogerbrugge N, Letteboer TG, Menko FH, Lindblom A, Mensenkamp A, Moller P, van Os TA, Rahner N, Redeker BJ, Olderode M, Spruijt L, Vos YJ, Wagner A, Morreau H, Hes FJ, Vasen HF, Tops CM, Wijnen JT, Nielsen M.

Genet Med. 2015 Jun 25. doi: 10.1038/gim.2015.83. [Epub ahead of print]

PMID:
26110232
3.

Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.

Ait Ouakrim D, Dashti SG, Chau R, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Leggett B, Macrae FA, Ahnen DJ, Casey G, Gallinger S, Haile RW, Le Marchand L, Thibodeau SN, Lindor NM, Newcomb PA, Potter JD, Baron JA, Hopper JL, Jenkins MA, Win AK.

J Natl Cancer Inst. 2015 Jun 24;107(9). pii: djv170. doi: 10.1093/jnci/djv170. Print 2015 Sep.

PMID:
26109217
4.

Risk Factors Associated with Colorectal Cancer in a Subset of Patients with Mutations in MLH1 and MSH2 in Taiwan Fulfilling the Amsterdam II Criteria for Lynch Syndrome.

Kamiza AB, Hsieh LL, Tang R, Chien HT, Lai CH, Chiu LL, Lo TP, Hung KY, Wang CY, You JF, Hsiung CA, Yeh CC.

PLoS One. 2015 Jun 8;10(6):e0130018. doi: 10.1371/journal.pone.0130018. eCollection 2015.

5.

Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer.

Kloth M, Ruesseler V, Engel C, Koenig K, Peifer M, Mariotti E, Kuenstlinger H, Florin A, Rommerscheidt-Fuss U, Koitzsch U, Wodtke C, Ueckeroth F, Holzapfel S, Aretz S, Propping P, Loeffler M, Merkelbach-Bruse S, Odenthal M, Friedrichs N, Heukamp LC, Zander T, Buettner R.

Gut. 2015 Apr 28. pii: gutjnl-2014-309026. doi: 10.1136/gutjnl-2014-309026. [Epub ahead of print]

PMID:
26001389
6.

PIK3CA Somatic Mutation Status in Relation to Patient and Tumor Factors in Racial/Ethnic Minorities with Colorectal Cancer.

Phipps AI, Ahnen DJ, Cheng I, Newcomb PA, Win AK, Burnett T.

Cancer Epidemiol Biomarkers Prev. 2015 Jul;24(7):1046-51. doi: 10.1158/1055-9965.EPI-15-0204. Epub 2015 May 20.

PMID:
25994739
7.

Lung cancer risk by years since quitting in 30+ pack year smokers.

Pinsky PF, Zhu CS, Kramer BS.

J Med Screen. 2015 Apr 29. pii: 0969141315579119. [Epub ahead of print]

PMID:
25926339
8.

Mismatch repair status and synchronous metastases in colorectal cancer: A nationwide cohort study.

Nordholm-Carstensen A, Krarup PM, Morton D, Harling H; ; on behalf of the Danish Colorectal Cancer Group.

Int J Cancer. 2015 Apr 28. doi: 10.1002/ijc.29585. [Epub ahead of print]

PMID:
25921209
9.

Clinical relevance of 8q23, 15q13 and 18q21 SNP genotyping to evaluate colorectal cancer risk.

Baert-Desurmont S, Charbonnier F, Houivet E, Ippolito L, Mauillon J, Bougeard M, Abadie C, Malka D, Duffour J, Desseigne F, Colas C, Pujol P, Lejeune S, Dugast C, Buecher B, Faivre L, Leroux D, Gesta P, Coupier I, Guimbaud R, Berthet P, Manouvrier S, Cauchin E, Prieur F, Laurent-Puig P, Lebrun M, Jonveaux P, Chiesa J, Caron O, Morin-Meschin ME, Polycarpe-Osaer F, Giraud S, Zaanan A, Bonnet D, Mansuy L, Bonadona V, El Chehadeh S, Duhoux F, Gauthier-Villars M, Saurin JC, Collonge-Rame MA, Brugières L, Wang Q, Bressac-de Paillerets B, Rey JM, Toulas C, Buisine MP, Bronner M, Sokolowska J, Hardouin A, Cailleux AF, Sebaoui H, Blot J, Tinat J, Benichou J, Frebourg T.

Eur J Hum Genet. 2015 Apr 15. doi: 10.1038/ejhg.2015.72. [Epub ahead of print]

PMID:
25873010
10.

Effect of metabolic syndrome and its components on survival in colorectal cancer: a prospective study.

Ahmadi A, Noroozi M, Pourhoseingholi MA, Hashemi-Nazari SS.

J Renal Inj Prev. 2015 Mar 1;4(1):15-9. doi: 10.12861/jrip.2015.05. eCollection 2015.

11.

DNA methylation combinations in adjacent normal colon tissue predict cancer recurrence: evidence from a clinical cohort study.

Kuan JC, Wu CC, Sun CA, Chu CM, Lin FG, Hsu CH, Kan PC, Lin SC, Yang T, Chou YC.

PLoS One. 2015 Mar 27;10(3):e0123396. doi: 10.1371/journal.pone.0123396. eCollection 2015.

12.

Validation of an online questionnaire for identifying people at risk of familial and hereditary colorectal cancer.

Kallenberg FG, IJspeert JE, Bossuyt PM, Aalfs CM, Dekker E.

Fam Cancer. 2015 Mar 24. [Epub ahead of print]

PMID:
25800523
13.

Smoking and survival of colorectal cancer patients: Population-based study from Germany.

Walter V, Jansen L, Hoffmeister M, Ulrich A, Chang-Claude J, Brenner H.

Int J Cancer. 2015 Mar 10. doi: 10.1002/ijc.29511. [Epub ahead of print]

PMID:
25758762
14.

Fertility after young onset colorectal cancer: a study of subjects with Lynch syndrome.

Stupart D, Win AK, Jenkins M, Winship IM.

Colorectal Dis. 2015 Mar 6. doi: 10.1111/codi.12940. [Epub ahead of print]

PMID:
25754680
15.

Smoking and survival in female breast cancer patients.

Padron-Monedero A, Tannenbaum SL, Koru-Sengul T, Miao F, Hansra D, Lee DJ, Byrne MM.

Breast Cancer Res Treat. 2015 Apr;150(2):395-403. doi: 10.1007/s10549-015-3317-3. Epub 2015 Feb 28.

PMID:
25724306
16.

Relationship between smoking and multiple colorectal cancers in patients with Japanese Lynch syndrome: a cross-sectional study conducted by the Japanese Society for Cancer of the Colon and Rectum.

Tanakaya K, Furukawa Y, Nakamura Y, Hirata K, Tomita N, Tamura K, Sugano K, Ishioka C, Yoshida T, Ishida H, Watanabe T, Sugihara K; HNPCC registry and genetic testing project of the Japanese Society for Cancer of the Colon and Rectum, Yamaguchi T, Ishikawa H, Matsubara N, Arai M, Moriya Y.

Jpn J Clin Oncol. 2015 Mar;45(3):307-10. doi: 10.1093/jjco/hyu218. Epub 2015 Jan 12.

PMID:
25583420
17.

Medullary Colorectal Carcinoma Revisited: A Clinical and Pathological Study of 102 Cases.

Knox RD, Luey N, Sioson L, Kedziora A, Clarkson A, Watson N, Toon CW, Cussigh C, Pincott S, Pillinger S, Salama Y, Evans J, Percy J, Schnitzler M, Engel A, Gill AJ.

Ann Surg Oncol. 2015 Jan 9. [Epub ahead of print]

PMID:
25572685
18.

Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing.

Chubb D, Broderick P, Frampton M, Kinnersley B, Sherborne A, Penegar S, Lloyd A, Ma YP, Dobbins SE, Houlston RS.

J Clin Oncol. 2015 Feb 10;33(5):426-32. doi: 10.1200/JCO.2014.56.5689. Epub 2015 Jan 5.

PMID:
25559809
19.

Diagnosis and management of DNA mismatch repair-deficient colorectal cancer.

Stadler ZK.

Hematol Oncol Clin North Am. 2015 Feb;29(1):29-41. doi: 10.1016/j.hoc.2014.09.008.

PMID:
25475571
20.

The evolution of colorectal cancer genetics-Part 1: from discovery to practice.

Schlussel AT, Gagliano RA Jr, Seto-Donlon S, Eggerding F, Donlon T, Berenberg J, Lynch HT.

J Gastrointest Oncol. 2014 Oct;5(5):326-35. doi: 10.3978/j.issn.2078-6891.2014.069. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk